Insider Stock Trading History of Mcdade Mark


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mcdade Mark since year 2005. The trader's CIK number is 1242126. At the time of this reporting, Mcdade Mark is the Director of Five Prime Therapeutics Inc . (stock ticker symbol FPRX). See this page for all insider trading activities at Five Prime Therapeutics Inc .

Note that in the past MCDADE MARK also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Mcdade Mark since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-10-03 FPRX Five Prime Therapeutics Inc Option Ex 12,601 1.54 19,405
2015-08-11 AIMT Aimmune Therapeutics, Inc. Buy 16,660 16.00 266,560
2015-07-17 N/A Phillips Edison Grocery Center Reit Ii, Inc. Buy 422 22.50 9,495
2015-05-06 N/A Phillips Edison Grocery Center Reit Ii, Inc. Buy 422 22.50 9,495
2007-01-17 PDLI Protein Design Labs Inc/de Sale 10,000 21.45 214,549
2007-01-17 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-16 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-16 PDLI Protein Design Labs Inc/de Sale 10,000 21.29 212,860
2007-01-12 PDLI Protein Design Labs Inc/de Sale 10,000 20.88 208,770
2007-01-12 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-11 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-11 PDLI Protein Design Labs Inc/de Sale 10,000 20.70 207,040
2007-01-10 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-10 PDLI Protein Design Labs Inc/de Sale 10,000 20.40 204,010
2007-01-09 PDLI Protein Design Labs Inc/de Sale 10,000 20.30 203,050
2007-01-08 PDLI Protein Design Labs Inc/de Sale 10,000 20.43 204,289
2007-01-09 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-08 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-05 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-05 PDLI Protein Design Labs Inc/de Sale 10,000 20.29 202,850
2007-01-03 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-04 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2007-01-03 PDLI Protein Design Labs Inc/de Sale 10,000 20.26 202,630
2007-01-04 PDLI Protein Design Labs Inc/de Sale 8,000 20.35 162,768
2006-01-04 PDLI Protein Design Labs Inc/de Sale 2,000 20.03 40,060
2006-01-17 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-17 PDLI Protein Design Labs Inc/de Sale 10,000 28.02 280,210
2006-01-13 PDLI Protein Design Labs Inc/de Sale 10,000 28.29 282,900
2006-01-13 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-12 PDLI Protein Design Labs Inc/de Sale 10,000 29.26 292,600
2006-01-12 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-11 PDLI Protein Design Labs Inc/de Sale 10,000 29.93 299,320
2006-01-11 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-10 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-10 PDLI Protein Design Labs Inc/de Sale 10,000 31.29 312,900
2006-01-09 PDLI Protein Design Labs Inc/de Sale 10,000 30.51 305,100
2006-01-09 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-06 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-06 PDLI Protein Design Labs Inc/de Sale 10,000 30.10 301,000
2006-01-05 PDLI Protein Design Labs Inc/de Sale 10,000 29.72 297,210
2006-01-05 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-04 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-04 PDLI Protein Design Labs Inc/de Sale 10,000 28.70 287,040
2006-01-03 PDLI Protein Design Labs Inc/de Option Ex 10,000 8.30 83,000
2006-01-03 PDLI Protein Design Labs Inc/de Sale 10,000 28.01 280,100

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcdade Mark (Director of Five Prime Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.